Sign up for this intimate roundtable to understand what the FDA is doing to support medical device innovation within obstetrical, gynecological and reproductive health.

• Gain tangible insights into how to leverage the work of the FDA to improve innovation pipelines and clinical trials.

This session homes in on a health condition that affects women at a significantly higher rate than men. Taking a 360 look at the latest insights and developments, this session covers innovative solutions that look to prevent osteoporosis, as well as those that look to manage the condition and novel research looking to address the root cause.

As many as 4 out of 5 people with an autoimmune disease are women. The question of why has plagued researchers for years. New research, however, is shedding the light on this age-old mystery for the first time. Join this presentation to hear more about this research and learn about how chromosomes play an important role in determining sex and gender differences. Consider what this means for innovation, and how it will impact other areas of women’s health. 

This presentation takes a look at an area of women’s health where AI and technology have had a profound impact in increasing access and improving outcomes through next generation imaging. Hear from experts leading the way as they unpack the latest developments and discuss it’s potential to transform women’s cancer outcomes

Join this session to learn about how recent understandings of the ways that women present differently from men in various disease areas have impacted the delivery and design of clinical trials to account for sex differences. Hear about the latest innovations driving change, including the role that AI and ML play in stratifying populations, and how remote clinical trials and telehealth are increasing access to clinical trials. Both of these factors play a crucial role in ensuring that more diversity and sex-focused trials take place

With an increase in publishing guidelines calling for more sex and gender specific research and better diversity and inclusion in clinical trials, this panel discussion considers how to promote accountability across the public and private sphere. How can we ensure that guidelines are adhered to and what role do public-private sector partnerships play in promoting better research practices? What do recent guidelines published by the FDA advocating for health equity in clinical trials really mean for those innovation in the space? Join this session to unpack these questions and to gain insight into how to ensure your business is successfully considering sex and gender throughout the R&D process.